Comparison of G-protein selectivity of human 5-HT2C and 5-HT1A receptors

被引:6
|
作者
Okada, M
Goldman, D
Linnoila, M
Iwata, N
Ozaki, N
Northup, JK
机构
[1] Osaka City Univ, Fac Med, Dept Publ Hlth, Abeno Ku, Osaka 5458585, Japan
[2] NIAAA, Neurogenet Lab, NIH, Rockville, MD 20852 USA
[3] NIAAA, Clin Studies Lab, NIH, Rockville, MD 20852 USA
[4] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4668550, Japan
[5] NIDCD, Biol Cellulaire Lab, NIH, Rockville, MD 20850 USA
来源
CURRENT STATUS OF DRUG DEPENDENCE / ABUSE STUDIES: CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY | 2004年 / 1025卷
关键词
D O I
10.1196/annals.1316.070
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We compared the ability of human 5-HT2C and 5-HT1A receptors to couple to selected G proteins expressed in insect Sf9 cells through simultaneous infection with recombinant baculoviruses. We also examined the coupling of G proteins to these same receptors in membranes derived from the Sf9 cells using in situ reconstitution with purified G proteins. Our data show that unoccupied 5-HT2C and 5-HT1A receptors can attain an activated conformation that is stabilized by interaction with specific G proteins. While high-affinity agonist binding to the 5-HT2C receptor was increased to a greater extent by Galpha(q) than by Galpha(i2), the high-affinity agonist binding to the 5-HT1A receptor was preferentially enhanced by Galpha(i2) coexpression. When the two 5-HT receptors were expressed in cells also expressing G proteins, both 5-HT2C and 5-HT1A receptors appear to activate Gai2 in preference to Gaq. In contrast, in situ reconstitution data show that 5-HT2C receptors robustly activate Get 9 and marginally activate Galpha(0) or Galpha(j), whereas 5-HT1A receptors only marginally activate Galpha(q) and robustly activate Galpha(0) and Galpha(i). These results suggest that the overexpression of receptor and potential G-protein coupling partners is Sf9 cells may lead to erroneous conclusions as to the signaling selectivity of receptors.
引用
收藏
页码:570 / 577
页数:8
相关论文
共 50 条
  • [31] Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice
    Halberstadt, Adam L.
    Sindhunata, Ivan S.
    Scheffers, Kees
    Flynn, Aaron D.
    Sharp, Richard F.
    Geyer, Mark A.
    Young, Jared W.
    NEUROPHARMACOLOGY, 2016, 107 : 364 - 375
  • [32] Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors
    Berg, KA
    Harvey, JA
    Spampinato, U
    Clarke, WP
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (12) : 625 - 630
  • [33] The serotonin (5-HT)2A and 5-HT2c receptors in nicotine dependence
    Zaniewska, Magdalena
    Filip, Malgorzata
    PHARMACOLOGICAL REPORTS, 2010, 62 : 10 - 10
  • [34] The role of 5-HT2A, 5-HT2C and 5HT3 serotonin receptors in the regulation of sleep
    Kantor, S
    Gerber, K
    Halasz, P
    Bagdy, G
    JOURNAL OF PHYSIOLOGY-LONDON, 2000, 526 : 66P - 67P
  • [35] The serotonin (5-HT)2A and 5-HT2C receptors in nicotine dependence
    Magdalena Zaniewska
    Małgorzata Filip
    Pharmacological Reports, 2010, 62 : 10 - 10
  • [36] Calmodulin interacts with and modulates 5-HT1a and 5-HT2a receptors
    Raymond, J. R.
    Gelasco, A. K.
    Turner, J. H.
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 101 : 58 - 58
  • [37] The therapeutic role of 5-HT1A and 5-HT2A receptors in depression
    Celada, P
    Puig, MV
    Amargós-Bosch, M
    Adell, A
    Artigas, F
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2004, 29 (04): : 252 - 265
  • [38] RNA editing of the human serotonin 5-HT2C receptor disrupts transactivation of the small G-protein RhoA
    McGrew, L
    Price, RD
    Hackler, E
    Chang, MSS
    Sanders-Bush, E
    MOLECULAR PHARMACOLOGY, 2004, 65 (01) : 252 - 256
  • [39] FUNCTIONAL SELECTIVITY OF 5-HT2C RECEPTOR AGONISTS
    Pausch, Mark
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 339 - 339
  • [40] Interplay between 5-HT2C and 5-HT1A receptors in the dorsal periaqueductal gray in the modulation of fear-induced antinociception in mice
    Baptista-de-Souza, Daniela
    Pelarin, Vinicius
    Canto-de-Souza, Lucas
    Nunes-de-Souza, Ricardo Luiz
    Canto-de-Souza, Azair
    NEUROPHARMACOLOGY, 2018, 140 : 100 - 106